By Joyce Tait
Successful and sustainable businesses in the Regenerative Medicine industry need to incorporate strategies to address key factors beyond individual business boundaries. These include legal, ethical and financial frameworks, distribution and logistics, and end users willingness to adopt and ability to pay. Business models need to be well adapted to the needs of this market and wil vary depending on whether the end product is a cellular therapy, a delivery system for cells, genes or small molecules or enabling tools and technologies for stimulating endogenous repair. The value systems for each of these types of products are likely to have unique features but will also need to be compliant with global regulatory and legal frameworks.
Showing posts with label global health innovation. Show all posts
Showing posts with label global health innovation. Show all posts
Friday, 25 June 2010
Friday, 26 February 2010
Press coverage for Innogen's Economics Director, Prof Mariana Mazzucato
Find out more about Mariana's work in the following media outlets:
Television
Academic expert in 'Inside Story', 22 minute TV programme on Toyota Recall and its impact. Presented by Mike Hanna. Produced by Al Jazeera English, first aired prime time on Al Jazeera English TV, 7 February 2010
Key role in the design and development of the film 'Rules of the Game', 30 minute TV film on innovation and the industry life-cycle, Featuring work and interviews by academic experts: Mariana Mazzucato, Paul David, and Clive Sinclair. Presented by PY Gerbeau. Produced by BBC, first aired prime time on BBC2, June 2002.
News
'Is R&D spending worth it?' (forthcoming Spring 2010) - contribution to the 'Excellence in Leadership', the Chartered Institute of Management Accountants business publication
'Economic Insight' column (Jan 2010) - opinion piece on 'to what extent throwing money at funding innovation helps keep a country ahead in the knowledge economy' in the Business XL publication
'Fixing the Broken Innovation Model' (Dec 2009) - opinion piece for Pharmaceutical Executive Europe
'Innovate to Stimulate' (Jan 2010) - article on Prof Mazzucato's inaugural address (25 March 2009): 'Do the best firms always win?' featured in Sesame magazine.
'Economic Recovery is a Slow and Painful Process' (Nov 2009) - Peter Bartram from the Financial Director quoting Professor Mazzucato on the economic growth rate in 2010.
'Winning Advantage Through Innovation' (Nov 2009) - Brett Matthews from the Business Today quoting Professor Mazzucato on why people are not investing and a discussion piece on the relationship between innovation and company growth.
'Study Probes Role of Finance in the Economy' (July 2009) - Market Research Industry Online highlights FINNOV, the OU grant awarded by the European Commission (http://www.finnov-fp7.eu/), led by Mariana Mazzucato
Television
Academic expert in 'Inside Story', 22 minute TV programme on Toyota Recall and its impact. Presented by Mike Hanna. Produced by Al Jazeera English, first aired prime time on Al Jazeera English TV, 7 February 2010
Key role in the design and development of the film 'Rules of the Game', 30 minute TV film on innovation and the industry life-cycle, Featuring work and interviews by academic experts: Mariana Mazzucato, Paul David, and Clive Sinclair. Presented by PY Gerbeau. Produced by BBC, first aired prime time on BBC2, June 2002.
News
'Is R&D spending worth it?' (forthcoming Spring 2010) - contribution to the 'Excellence in Leadership', the Chartered Institute of Management Accountants business publication
'Economic Insight' column (Jan 2010) - opinion piece on 'to what extent throwing money at funding innovation helps keep a country ahead in the knowledge economy' in the Business XL publication
'Fixing the Broken Innovation Model' (Dec 2009) - opinion piece for Pharmaceutical Executive Europe
'Innovate to Stimulate' (Jan 2010) - article on Prof Mazzucato's inaugural address (25 March 2009): 'Do the best firms always win?' featured in Sesame magazine.
'Economic Recovery is a Slow and Painful Process' (Nov 2009) - Peter Bartram from the Financial Director quoting Professor Mazzucato on the economic growth rate in 2010.
'Winning Advantage Through Innovation' (Nov 2009) - Brett Matthews from the Business Today quoting Professor Mazzucato on why people are not investing and a discussion piece on the relationship between innovation and company growth.
'Study Probes Role of Finance in the Economy' (July 2009) - Market Research Industry Online highlights FINNOV, the OU grant awarded by the European Commission (http://www.finnov-fp7.eu/), led by Mariana Mazzucato
Thursday, 14 January 2010
Where are the users in the Global Health Research and Innovation System?
Dr. Rebecca Hanlin, Director of Health Innovation at the ESRC Innogen Centre
During many of the discussions held at Forum 2009 towards the end of last year in Havana, Cuba, a particular set of users (patients and civil society members) were frequently missing. One concept discussed at the meeting and in a commentary piece published at the time in The Lancet was that of a Global Health Research and Innovation System. This concept acknowledges the need to consider more systemically the wide range of actors, stimulus and challenges impacting the ability to innovate (new) health related products and services to address the health of the poorest in the world. However, the current conceptualisation of this system put forward ignores the valuable role users play in the innovation process.
This is despite an increasing recognition of the role of users within academic thinking around innovation more generally. There is a growing recognition that innovation is disruptive and often takes place as a result of those who, or to address groups who, are ‘below the radar’ thus recognizing the role of low income populations at the bottom of the pyramid. Much of this has been user driven innovation whereby innovation takes place in response to the needs of users while other innovation actually involves the user in the innovation process. Considering these forms of innovation provide one means to overcome the mismatches affecting innovation of health related products and services for those who need them most.
Further information:
[1] http://www.globalforumhealth.org/Forum-2009
[1] Matlin, S.A. and Samuels, G.M.R. (2009) “The Global Health Research and Innovation System (GHRIS)” The Lancet Vol. 374, pp.1662-3
[1] DPP (2009) BELOW THE RADAR: WHAT DOES INNOVATION IN THE ASIAN DRIVER ECONOMIES HAVE TO OFFER OTHER LOW INCOME ECONOMIES? Innogen Working Paper 69 January 2009
[1] Prahalad, C.K. (2004) The Fortune at the Bottom of the Pyramid: Eradicating Poverty Through Profits Wharton School Publishing[1] Hanlin, R. and Sutz, J. (2009) Where are the flags of our fathers? Rethinking linkages between social policies and innovation policies Innogen Working Paper (forthcoming)
During many of the discussions held at Forum 2009 towards the end of last year in Havana, Cuba, a particular set of users (patients and civil society members) were frequently missing. One concept discussed at the meeting and in a commentary piece published at the time in The Lancet was that of a Global Health Research and Innovation System. This concept acknowledges the need to consider more systemically the wide range of actors, stimulus and challenges impacting the ability to innovate (new) health related products and services to address the health of the poorest in the world. However, the current conceptualisation of this system put forward ignores the valuable role users play in the innovation process.
This is despite an increasing recognition of the role of users within academic thinking around innovation more generally. There is a growing recognition that innovation is disruptive and often takes place as a result of those who, or to address groups who, are ‘below the radar’ thus recognizing the role of low income populations at the bottom of the pyramid. Much of this has been user driven innovation whereby innovation takes place in response to the needs of users while other innovation actually involves the user in the innovation process. Considering these forms of innovation provide one means to overcome the mismatches affecting innovation of health related products and services for those who need them most.
Further information:
[1] http://www.globalforumhealth.org/Forum-2009
[1] Matlin, S.A. and Samuels, G.M.R. (2009) “The Global Health Research and Innovation System (GHRIS)” The Lancet Vol. 374, pp.1662-3
[1] DPP (2009) BELOW THE RADAR: WHAT DOES INNOVATION IN THE ASIAN DRIVER ECONOMIES HAVE TO OFFER OTHER LOW INCOME ECONOMIES? Innogen Working Paper 69 January 2009
[1] Prahalad, C.K. (2004) The Fortune at the Bottom of the Pyramid: Eradicating Poverty Through Profits Wharton School Publishing[1] Hanlin, R. and Sutz, J. (2009) Where are the flags of our fathers? Rethinking linkages between social policies and innovation policies Innogen Working Paper (forthcoming)
Subscribe to:
Posts (Atom)